• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,264.33 736.38
( 0.97%)
Global Indices
Nasdaq
51,705.57 482.31
(0.94%)
Dow Jones
7,575.20 122.74
(1.65%)
Hang Seng
69,318.21 3,298.17
(5.00%)
Nikkei 225
10,435.69 -36.03
(-0.34%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Phoenix Mills Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
503100
INE211B01039
153.8924836
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PHOENIXLTD
224.08
66116.99
EPS(TTM)
Face Value()
Div & Yield %
8.25
2
0.14
 

orchasp limited
Astrazeneca Pharma India standalone net profit declines 22.95% in the March 2026 quarter
May 27,2026
Net profit of Astrazeneca Pharma India declined 22.95% to Rs 44.88 crore in the quarter ended March 2026 as against Rs 58.25 crore during the previous quarter ended March 2025. Sales rose 20.42% to Rs 578.61 crore in the quarter ended March 2026 as against Rs 480.48 crore during the previous quarter ended March 2025.

For the full year,net profit rose 62.02% to Rs 187.52 crore in the year ended March 2026 as against Rs 115.74 crore during the previous year ended March 2025. Sales rose 32.59% to Rs 2275.58 crore in the year ended March 2026 as against Rs 1716.29 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales578.61480.48 20 2275.581716.29 33
OPM %10.5317.98 -11.5114.80 -
PBDT64.82101.84 -36 286.03293.14 -2
PBT59.2284.15 -30 257.45253.15 2
NP44.8858.25 -23 187.52115.74 62